MedPath

Double-blind placebo controlled study of the adjunctive effect of tropisetron on cognitive deficits in schizophrenia

Not Applicable
Conditions
schizophrenia
Registration Number
JPRN-UMIN000003084
Lead Sponsor
Department of Psychiatry, Chiba University Graduate School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

history of other neurologic illness, pregnant or suckling are excluded

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
cognitive function of the patient at 4, and 8 weeks after starting
Secondary Outcome Measures
NameTimeMethod
mental status, quality of life, and so on of the patient at 4, and 8 weeks after starting
© Copyright 2025. All Rights Reserved by MedPath